Kloner, Robert A <br/><br/>
Cardiovascular effects of the 3 phosphodiesterase-5 inhibitors approved for the treatment of erectile dysfunction.  [electronic resource] 

 -  Circulation  Nov 2004 
 - 3149-55 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1524-4539 
<br/><br/><label>Standard No.: </label>10.1161/01.CIR.0000146906.42375.D3  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>3',5'-Cyclic-GMP Phosphodiesterases<br/>Adrenergic alpha-Antagonists--pharmacology<br/>Arteriosclerosis--complications<br/>Blood Pressure--drug effects<br/>Carbolines--adverse effects<br/>Contraindications<br/>Coronary Disease--complications<br/>Cyclic GMP--metabolism<br/>Cyclic Nucleotide Phosphodiesterases, Type 5<br/>Drug Interactions<br/>Endothelium, Vascular--drug effects<br/>Erectile Dysfunction--drug therapy<br/>Heart Rate--drug effects<br/>Humans<br/>Hypotension--chemically induced<br/>Imidazoles--adverse effects<br/>Isosorbide Dinitrate--analogs & derivatives<br/>Male<br/>Molecular Structure<br/>Myocardial Infarction--chemically induced<br/>Nitric Oxide Donors--pharmacology<br/>Nitroglycerin--pharmacology<br/>Phosphodiesterase Inhibitors--adverse effects<br/>Phosphoric Diester Hydrolases--drug effects<br/>Piperazines--adverse effects<br/>Purines<br/>Randomized Controlled Trials as Topic<br/>Sildenafil Citrate<br/>Sulfones--adverse effects<br/>Tadalafil<br/>Triazines--adverse effects<br/>Vardenafil Dihydrochloride<br/>Vasodilation--drug effects<br/>Vasodilator Agents--adverse effects